BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24041959)

  • 21. Inhibition of c-Abl tyrosine kinase activity by filamentous actin.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2001 Jul; 276(29):27104-10. PubMed ID: 11309382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation.
    Hirao N; Sato S; Gotoh T; Maruoka M; Suzuki J; Matsuda S; Shishido T; Tani K
    FEBS Lett; 2006 Nov; 580(27):6464-70. PubMed ID: 17101133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cofilin nuclear-cytoplasmic shuttling affects cofilin-actin rod formation during stress.
    Munsie LN; Desmond CR; Truant R
    J Cell Sci; 2012 Sep; 125(Pt 17):3977-88. PubMed ID: 22623727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
    Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear localization signal and phosphorylation of Serine350 specify intracellular localization of DRAK2.
    Kuwahara H; Nishizaki M; Kanazawa H
    J Biochem; 2008 Mar; 143(3):349-58. PubMed ID: 18084041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of TGF-β-induced Smad3 activity by c-Abl-mediated tyrosine phosphorylation of its coactivator SKI-interacting protein (SKIP).
    Kuki K; Yamaguchi N; Iwasawa S; Takakura Y; Aoyama K; Yuki R; Nakayama Y; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1045-1051. PubMed ID: 28666867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Abl induces stabilization of histone deacetylase 1 (HDAC1) in a kinase activity-dependent manner.
    Aoyama K; Yamaguchi N; Yuki R; Morii M; Kubota S; Hirata K; Abe K; Honda T; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    Cell Biol Int; 2015 Apr; 39(4):446-56. PubMed ID: 25561363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.
    Hu H; Bliss JM; Wang Y; Colicelli J
    Curr Biol; 2005 May; 15(9):815-23. PubMed ID: 15886098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress.
    Nihira K; Taira N; Miki Y; Yoshida K
    Oncogene; 2008 Dec; 27(58):7285-95. PubMed ID: 18794806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
    Fan PD; Cong F; Goff SP
    Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Abl tyrosine kinase plays a critical role in β2 integrin-dependent neutrophil migration by regulating Vav1 activity.
    Tong H; Zhao B; Shi H; Ba X; Wang X; Jiang Y; Zeng X
    J Leukoc Biol; 2013 Apr; 93(4):611-22. PubMed ID: 23325923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
    Welch PJ; Wang JY
    Cell; 1993 Nov; 75(4):779-90. PubMed ID: 8242749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.
    Raina D; Ahmad R; Kumar S; Ren J; Yoshida K; Kharbanda S; Kufe D
    EMBO J; 2006 Aug; 25(16):3774-83. PubMed ID: 16888623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport.
    Lewis JM; Baskaran R; Taagepera S; Schwartz MA; Wang JY
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15174-9. PubMed ID: 8986783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abl kinase interacts with and phosphorylates vinexin.
    Mitsushima M; Takahashi H; Shishido T; Ueda K; Kioka N
    FEBS Lett; 2006 Jul; 580(17):4288-95. PubMed ID: 16831423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse.
    Huang Y; Comiskey EO; Dupree RS; Li S; Koleske AJ; Burkhardt JK
    Blood; 2008 Jul; 112(1):111-9. PubMed ID: 18305217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's disease.
    Gonzalez-Zuñiga M; Contreras PS; Estrada LD; Chamorro D; Villagra A; Zanlungo S; Seto E; Alvarez AR
    Mol Cell; 2014 Oct; 56(1):163-73. PubMed ID: 25219501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway.
    Burton EA; Oliver TN; Pendergast AM
    Mol Cell Biol; 2005 Oct; 25(20):8834-43. PubMed ID: 16199863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.